Average Insider

Where insiders trade, we follow

Vivos Therapeutics, Inc. ($VVOS)
Accession: 0002074003-26-000008
Apr 2, 2026
๐Ÿ“ˆ Chart on TradingView๐Ÿ’ฐ Financials on Finviz
52W Low$1.08
Current$1.323.4% above low, 96.6% below high
52W High$7.95

Filing Information

Accession Number0002074003-26-000008
Form Type4
Filing DateApr 2, 2026
DocumentView SEC Filing
Transactions
5
Total Shares
5,350,746
Total Value
$7,169,999.64
P&L
-1.5% ($107,014.92)

Transactions

NameTitleSecurityDerivativeTransaction DateTypeSharesPriceTotal CostShares AfterDirect/IndirectNature of OwnershipActions
Skaff Michael C
10% Owner
Common Stock
โ€”Mar 31, 2026Purchase1,044,777$1.34$1,400,001.181,044,777IndirectBy V-CO Investors 3 LLCView Details
Skaff Michael C
10% Owner
Common Stock
โ€”Mar 31, 2026Purchase308,848$1.34$413,856.321,353,625IndirectBy V-CO Investors 3 LLCView Details
Skaff Michael C
10% Owner
Pre-Funded Warrant
(Common Stock)
DerivativeMar 31, 2026Purchase429,957$1.34$576,142.38429,957IndirectBy V-CO Investors 3 LLCView Details
Skaff Michael C
10% Owner
Series A Common Stock Warrant
(Common Stock)
DerivativeMar 31, 2026Purchase1,783,582$1.34$2,389,999.881,783,582IndirectBy V-CO Investors 3 LLCView Details
Skaff Michael C
10% Owner
Series B Common Stock Warrant
(Common Stock)
DerivativeMar 31, 2026Purchase1,783,582$1.34$2,389,999.881,783,582IndirectBy V-Co Investors 3 LLCView Details
Version: v26.3.33